| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |